Click here to BLOCK YOUR CONTENT SPACE IN OUR NEXT ISSUES
|
|
|
Industry Insights |
|
|
CDMO Services Transforming The Pharmaceutical Landscape
The COVID-19 pandemic transformed the API CDMO market, with CDMOs playing a pivotal role in vaccine production and the growing significance of Asia-Pacific.
|
|
|
|
|
|
|
|
|
|
Elevating Biopharmaceutical Projects With The Right CDMO
When choosing a CDMO in biopharma, customer-centricity, adaptability, and regulatory knowledge, along with a cohesive team must be prioritized for success.
|
|
|
|
|
|
Global Vaccine Production Drives Pharmaceutical CDMO Market
Pharmaceutical CDMO market to grow at 7.29% CAGR by the year 2028, influenced by analytics, CMO-CRO transformation, COVID-19 impact, and Asia-Pacific expansion.
|
|
|
|
|
|
|
|
|
|
AAV Therapy Collaboration Amidst $2.57B CDMO Market Surge
AAV-focused gene therapy CDMO market is anticipated to reach USD 2.57 billion by 2033, driven by clinical activities, collaborations, and growth challenges.
|
|
|
|
|
|
Unlocking Value-Based Pricing Strategies In Pharma CDMOs
CDMOs in the pharma sector must overhaul pricing strategies, adopt value-based models, and offer comprehensive end-to-end solutions for optimal competitiveness.
|
|
|
|
|
|
|
|
|
|
CDMO With Packaging Specialization Reports Promising Future
CDMOs offer diverse pharmaceutical services, including eco-friendly packaging, and labeling solutions; North America leads, and Asia-Pacific shows high growth.
|
|
|
|
|
|